Author Archives: Patricia Inacio PhD

‘Multimorbidity’ More Likely in Axial Spondyloarthropathy, Linked to Worse Outcomes, Irish Study Finds

People with axial spondyloarthropathy are more prone to develop additional disorders — called “multimorbidity” — which is associated with worse disease outcomes, according to a recent Irish study. The study, “Multimorbidity is Common in Axial Spondyloarthropathy and is Associated with Worse Disease Outcomes: Results from the ASRI cohort,”…

Humira of Benefit Over Long Term to Nonradiographic Axial Spondyloarthritis Patients, Study Reports

Long-term treatment with Abbvie‘s adalimumab, sold as Humira, led to sustained clinical remission accompanied by better physical abilities in patients with nonradiographic axial spondyloarthritis (nr-axSpA). “Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long-term open-label adalimumab treatment: 3-year results of the ABILITY-1 trial”…